Showing results (1121-1130 of 2,755) with videos related to

Sort By:
Pageof 276
Pharmacogenomics|December 17, 2013
Pharmacogenetics of taste: turning bitter pills sweet?Mariëlle J Nagtegaal, Jesse J Swen, Lidwien M Hanff, et al.
Pharmacogenomics|November 28, 2013
Pharmacogenetics of the nuclear hormone receptors: the missing link between environment and drug effects?Elena De Mattia, Eva Dreussi, Erika Cecchin, et al.
Pharmacogenomics|March 31, 2010
Advances in pharmacogenomics technologiesC Ramana Bhasker, Gary Hardiman
Pharmacogenomics|March 31, 2010
Multiplex genotyping of CYP3A4, CYP3A5, CYP2C9 and CYP2C19 SNPs using MALDI-TOF mass spectrometryMatteo Falzoi, Alessandra Mossa, Elena Congeddu, et al.
Pharmacogenomics|May 28, 2010
CD40-1C>T polymorphism (rs1883832) is associated with brain vessel reocclusion after fibrinolysis in ischemic strokeAlberto del Río-Espínola, Israel Fernández-Cadenas, Marta Rubiera, et al.
Pharmacogenomics|May 28, 2010
Association of HTR2C, but not LEP or INSIG2, genes with antipsychotic-induced weight gain in a German sampleCarolin Opgen-Rhein, Eva Janina Brandl, Daniel J Müller, et al.
Pharmacogenomics|May 28, 2010
Drug transporter pharmacogenetics in nucleoside-based therapiesEkaitz Errasti-Murugarren, Marçal Pastor-Anglada
Pharmacogenomics|April 27, 2010
HTR2C promoter polymorphisms are associated with risperidone efficacy in Chinese female patientsBao-Cheng Liu, Jing Zhang, Lei Wang, et al.
Pharmacogenomics|April 27, 2010
Role of genetic variation in the cannabinoid type 1 receptor gene (CNR1) in the pathophysiology of human obesityDorit Schleinitz, Solveig Carmienke, Yvonne Böttcher, et al.
Pharmacogenomics|October 24, 2006
Therapeutic targets and biomarkers identified in cancer choline phospholipid metabolismKristine Glunde, Natalie J Serkova
Pageof 276